MedSkin Solutions Dr. Suwelack AG announces their partnership with Access Pro Medical and the launch of their flagship medical device MatriDerm

MatriDerm US portfolio

MatriDerm US portfolio. (Credit: Medskin Solutions Dr. Suwelack AG.)

MedSkin Solutions Dr. Suwelack AG announces that their new US partner, Access Pro Medical, launched MatriDerm® in the US market at the Southern Region Burn Conference in New Orleans last week.

Jason Gugliuzza, Vice President MedCare Solutions at MedSkin Solutions Dr. Suwelack AG, “It took a lot of time and effort to be able to launch MatriDerm® in the US market. Therefore, we are very happy that we now reached this significant milestone with a great partner in Access Pro Medical.”

“We are pleased to partner with MedSkin Solutions Dr. Suwelack AG to bring the truly exceptional technology of MatriDerm® to the US. Many US surgeons have been waiting to offer the benefits of MatriDerm® to their patients. We are happy we can now provide MatriDerm® to achieve best-in-class results in partial- and full-thickness wounds.” says Chris Calvert, CEO at Access Pro Medical.

MatriDerm® is a single-use three-dimensional acellular dermal matrix composed of bovine collagen fibers and bovine elastin. MatriDerm® is indicated for use in the management of wounds including partial and full-thickness wounds, chronic wounds (e.g. pressure ulcers, venous ulcers, diabetic ulcers), surgical wounds (donor sites/grafts, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), partial thickness burns, trauma wounds (abrasions, lacerations and skin tears) and draining wounds. MatriDerm® received FDA 510(k) clearance in January this year.

Source: Company Press Release